P1.06 * Phase I study of the combination of alisertib (MLN8237) and gemcitabine in advanced solid tumors
Semrad, T., Kelly, K., Gandara, D., Riess, J., Li, T., Yu, A., Mack, P., Kim, E.Volume:
26
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdv090.6
Date:
March, 2015
File:
PDF, 29 KB
english, 2015